Chase AIPricingFAQs
Display currency
Loading news…

Precede Biosciences

ActiveOperating status — whether the company still runs independently. “Closed” usually means it was acquired, merged, or shut down.🔥 LowHeat score — how much recent activity & attention the company has (web traffic, news, hiring).📈 High growthGrowth score — momentum trend across web traffic, headcount and other growth signals.
Boston, Massachusetts, United States Founded 2005 11-50 employees For Profit

Precede Biosciences is a biotechnology company that provides a blood-based approach to reveal disease-defining transcriptional biology.

Total Funding
Available in Pro
Last Funding
Available in Pro
Acquisitions
0
Monthly Visits
Available in Pro
Contacts
5
Patents
7
2 trademarks

Company Details

Funding & Financials

Pro
Total funding
Funding rounds
Last funding
Last funding type
Last funding date
Funding status
Total equity funding
Revenue range

IPO & Stock

IPO status
Private

Web Traffic

Pro
Monthly visits
Global traffic rank
6-mo avg visits
Visit duration (s)
Pages / visit
Bounce rate
Rank change (mo)

Technology & IP

Active technologies
2
Patents granted
7
Trademarks
2

Company Info

Founded
2005
Employees
11-50
Operating status
Active
Company type
For Profit
Org types
company
Founders
1
News articles
35
HQ
Boston, Massachusetts, United States
Region
Greater Boston Area, East Coast, New England

Signals & Scores

Heat score
Low
Growth score
High
Trend (7d)
0.8
Trend (30d)
-0.7
Trend (90d)
-0.3
Last leadership hire
Jan 12, 2026

Key People at Precede Biosciences

Co-Founder and CEO
5
professional contacts at Precede Biosciences
Contact execs at Precede Biosciences

Explore 200,000+ acquisitions — free

Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.

Explore all acquisitions

Recent News related to Precede Biosciences

Loading news…

FAQs about Precede Biosciences

People who checked this page also checked these

Browse the full Acquirezy directory.
Precede Biosciences - Company Profile, Full Acquisitions List, Funding and Investments